2.15
前日終値:
$2.09
開ける:
$2.13
24時間の取引高:
984.07K
Relative Volume:
1.44
時価総額:
$152.07M
収益:
$299.48M
当期純損益:
$-86.45M
株価収益率:
-1.4333
EPS:
-1.5
ネットキャッシュフロー:
$-17.32M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-9.66%
6か月 パフォーマンス:
-43.72%
1年 パフォーマンス:
-60.84%
Health Catalyst Inc Stock (HCAT) Company Profile
名前
Health Catalyst Inc
セクター
電話
801-708-6800
住所
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, DOCS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
2.15 | 147.83M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
183.65 | 30.22B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
54.91 | 9.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.68 | 6.92B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
79.45 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.73 | 6.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-27 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-08-08 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-04-09 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-01-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2024-01-03 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-12-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-11-13 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-05-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 開始されました | Stephens | Equal-Weight |
| 2023-04-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 開始されました | Wells Fargo | Equal Weight |
| 2022-10-25 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-05 | ダウングレード | Stifel | Buy → Hold |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-03-17 | アップグレード | Jefferies | Hold → Buy |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-10-14 | 開始されました | BTIG Research | Buy |
| 2021-04-29 | 再開されました | JP Morgan | Overweight |
| 2020-12-08 | 開始されました | Berenberg | Buy |
| 2020-07-14 | 開始されました | Citigroup | Buy |
| 2020-06-18 | 開始されました | Stifel | Buy |
| 2020-06-15 | 再開されました | Evercore ISI | Outperform |
| 2020-05-15 | 開始されました | Guggenheim | Buy |
| 2020-04-21 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-04-13 | 開始されました | SVB Leerink | Outperform |
| 2020-04-02 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-20 | 開始されました | Raymond James | Strong Buy |
| 2019-10-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 開始されました | Evercore ISI | Outperform |
| 2019-08-19 | 開始されました | Goldman | Buy |
| 2019-08-19 | 開始されました | JP Morgan | Overweight |
| 2019-08-19 | 開始されました | Piper Jaffray | Overweight |
| 2019-08-19 | 開始されました | SVB Leerink | Outperform |
| 2019-08-19 | 開始されました | SunTrust | Buy |
| 2019-08-19 | 開始されました | William Blair | Outperform |
すべてを表示
Health Catalyst Inc (HCAT) 最新ニュース
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Why Health Catalyst (HCAT) Stock Is Trading Lower Today - Finviz
How Health Catalyst Turns Analytics Into Action Clinicians Actually Use - Healthcare IT Today
Bear Alert: What is the cash position of GOGOQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a Compelling 76.94% Upside Potential - DirectorsTalk Interviews
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Analyst Calls: What is the dividend yield of Snowflake IncJuly 2025 Momentum & Long-Term Growth Portfolio Plans - baoquankhu1.vn
How The New Price Target Is Reframing Health Catalyst’s Story And Fair Value - Yahoo Finance
Support Test: Should I set a stop loss on Health Catalyst IncJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Navigating 2026: How health systems can thrive amid AI, labor and consumer pressures - Modern Healthcare
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Health Catalyst Announces Chief Commercial Officer Transition Plan - TipRanks
Health Catalyst, Inc. Announces Executive Changes - marketscreener.com
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, Inc (HCAT) Stock Analysis: Evaluating the 68% Potential Upside for Investors - DirectorsTalk Interviews
Why Clinical Data Analytics Is Becoming One of Healthcare’s Fastest-Growing Markets? - GlobeNewswire Inc.
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks - Barchart.com
Nasdaq Moves: What are Health Catalyst Incs recent SEC filings showingMarket Movers & Daily Chart Pattern Signals - baoquankhu1.vn
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know - The Globe and Mail
Market Outlook: Can Health Catalyst Inc stock weather global recessionStop Loss & Risk Managed Investment Strategies - Bộ Nội Vụ
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide - Investing.com Australia
Health Catalyst stock reiterated as Buy at Stifel despite 2026 revenue guide By Investing.com - Investing.com South Africa
HCAT Projects Strong Client Growth and EBITDA Goals for FY25 - GuruFocus
(HCAT) Health Catalyst Expects 2025 Revenue to Slightly Exceed Guidance of About $310 Million - marketscreener.com
Health Catalyst drives AI in healthcare to cut costs - Traders Union
Surprises Report: Is Health Catalyst Inc stock a top pick in earnings seasonJuly 2025 Outlook & Verified Swing Trading Watchlists - moha.gov.vn
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - Улправда
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - Улправда
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - Улправда
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - Улправда
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - Улправда
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Signal Recap: Is Health Catalyst Inc stock oversold or undervaluedGap Down & Weekly High Return Stock Opportunities - moha.gov.vn
Investor Mood: Can Health Catalyst Inc stock rebound after recent weaknessWeekly Stock Analysis & Safe Entry Point Identification - Bộ Nội Vụ
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst Inc (HCAT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):